SPONSOR
First Affiliated Hospital of Wenzhou Medical University
Total Trials
2
Recruiting
2
Phases
Phase 2, Phase 4
Conditions studied: Hepatobiliary MalignancyFluoxetineAnxiety DisordersDepression DisordersNonalcoholic Fatty Liver DiseaseChronic Hepatitis b
First Affiliated Hospital of Wenzhou Medical University is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Hepatobiliary Malignancy, Fluoxetine, Anxiety Disorders, Depression Disorders.
The trial portfolio spans Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — First Affiliated Hospital of Wenzhou Medical University
How many clinical trials has First Affiliated Hospital of Wenzhou Medical University sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by First Affiliated Hospital of Wenzhou Medical University, of which 2 are actively recruiting participants. These trials cover conditions including Hepatobiliary Malignancy, Fluoxetine, Anxiety Disorders. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does First Affiliated Hospital of Wenzhou Medical University research focus on?
First Affiliated Hospital of Wenzhou Medical University clinical trials span Hepatobiliary Malignancy, Fluoxetine, Anxiety Disorders, Depression Disorders, Nonalcoholic Fatty Liver Disease, and additional conditions. The research pipeline includes Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a First Affiliated Hospital of Wenzhou Medical University clinical trial?
To participate in a First Affiliated Hospital of Wenzhou Medical University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all First Affiliated Hospital of Wenzhou Medical University trials with current recruitment status updated daily.
Clinical Trials by First Affiliated Hospital of Wenzhou Medical University
NCT07174947 Phase 2
Recruiting
SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety
Hepatobiliary Malignancy
NCT06368882 Phase 4
Recruiting
Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）
Nonalcoholic Fatty Liver Disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology